Skip to main content

Correction: Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway

Correction: J Exp Clin Cancer Res 37, 21 (2018)

https://doi.org/10.1186/s13046-018-0695-5

Following publication of the original article [1], an error was identified in the image of PHB Control and Paclitaxel (10 mg/kg) in Fig. 5d.

Fig. 5
figure 1

FL3 inhibits growth of UCB tumor xenografts in vivo. a The xenograft tumors were isolated from mice at the end of study. b Tumor volumes were recorded from the date of injection to the end of the study (mean, n = 7). c Histograms present the mean tumor weight in each group, means ± SD (n = 7). **P < 0.01, ***P < 0.001 indicates a significant difference between FL3-treated mice and control mice. d Tumors were embedded in paraffin and 5 μm thick sections were used for immunohistochemistry analysis with PHB or GADD45α antibody. e Body weights of mice were recorded along with the records of tumor volumes as dashed lines (mean, n = 7). f Main organs including heart, kidney, liver, and lung were removed from mice and embedded in paraffin for further hematoxylin eosin staining

The correction does not have any effect on the results or conclusions of the paper. The original article has been corrected.

Reference

  1. Yuan G, Chen X, Liu Z, et al. Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway. J Exp Clin Cancer Res. 2018;37:21. https://doi.org/10.1186/s13046-018-0695-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Laurent Désaubry, Fangjian Zhou or Dan Xie.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yuan, G., Chen, X., Liu, Z. et al. Correction: Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway. J Exp Clin Cancer Res 41, 291 (2022). https://doi.org/10.1186/s13046-022-02502-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13046-022-02502-2